Kisspeptin-10
Hypothalamic neuropeptide regulating GnRH and reproductive hormone axis.
Key Benefits
directly activates hypothalamic GnRH neurons for hormonal cascade
drives pituitary gonadotropin secretion for testosterone and fertility support
master regulator of reproductive endocrine function
used in clinical studies for hypogonadism and fertility
Active Signaling Pathway
Investigated Pathways
Proposed Mechanism
Kisspeptin-10 binds the KISS1R (GPR54) receptor on GnRH neurons in the hypothalamus, triggering pulsatile GnRH release. This activates the pituitary to secrete LH and FSH, which in turn stimulate gonadal steroidogenesis. It is the master regulator of the reproductive endocrine axis.
Research Highlights
- Single IV dose shown to increase LH by 10–20× in healthy volunteers
- Used in clinical research to diagnose and treat hypogonadotropic hypogonadism
- Demonstrated role in puberty onset and fertility regulation
- Research shows potential for testosterone optimization in males with secondary hypogonadism
Evidence is primarily from in vitro cell studies and animal models. Human data is limited or absent.
For research use only — not for human consumption. No treatment claims.
Full Research Hub →Recommended Stacks
Kisspeptin-10 is a key compound in these curated research stacks. Pair it with synergistic peptides for enhanced outcomes.
Hormonal Vitality Stack
HPG axis activation + melanocortin optimization — the complete vitality and libido research protocol.
How long will one vial last?
Based on standard research protocols, here's exactly what to expect from a single 5mg vial — and when to plan your next order.
Vial supply estimate is based on standard research protocol volumes. Actual duration will vary based on your specific protocol design.
Scientific Background
Mechanism of Action
Kisspeptin-10 binds the KISS1R (GPR54) receptor on GnRH neurons in the hypothalamus, triggering pulsatile GnRH release. This activates the pituitary to secrete LH and FSH, which in turn stimulate gonadal steroidogenesis. It is the master regulator of the reproductive endocrine axis.
Clinical Context
Kisspeptin is now recognized as the primary upstream regulator of the HPG axis. Clinical trials are ongoing for its use in fertility treatment and hormonal disorders.
Research Highlights
- Single IV dose shown to increase LH by 10–20× in healthy volunteers
- Used in clinical research to diagnose and treat hypogonadotropic hypogonadism
- Demonstrated role in puberty onset and fertility regulation
- Research shows potential for testosterone optimization in males with secondary hypogonadism
Storage & Reconstitution
Key Studies
Kisspeptin-10 stimulates LH secretion in healthy men
Dhillo WS et al.
Single IV dose of kisspeptin-10 increased LH by 10–20× in healthy male volunteers, confirming potent HPG axis activation.
PubMed →Kisspeptin-54 stimulates gonadotropin release in hypogonadal men
Jayasena CN et al.
Kisspeptin administration restored LH pulsatility and testosterone levels in men with hypogonadotropic hypogonadism.
PubMed →Kisspeptin and fertility
Jayasena CN et al.
Kisspeptin-10 pulsatile administration successfully triggered ovulation in women with hypothalamic amenorrhea.
PubMed →Pharmacokinetics
Bioavailability indicates how much of the compound reaches systemic circulation. Peak plasma is when blood levels are highest. Half-life determines dosing frequency — compounds with short half-lives require more frequent dosing to maintain therapeutic levels.
The volume of distribution reflects how widely the compound distributes into tissues. A higher Vd means the compound concentrates in tissues rather than staying in plasma.
Receptor Binding Profile
Triggers pulsatile GnRH release from hypothalamic neurons
Activates LH and FSH secretion from pituitary
Stimulates gonadal steroidogenesis — testosterone in males, estrogen in females
Side Effects & Adverse Events
- Injection site reactions
- Mild flushing
- Headache
- Nausea
- None documented at research doses
Contraindications & Interactions
Synergistic Compounds
Kisspeptin optimizes the HPG axis (testosterone/estrogen) while sermorelin optimizes the GH/IGF-1 axis — comprehensive hormonal optimization.
Kisspeptin-10 50 mcg SubQ AM + Sermorelin 300 mcg SubQ pre-sleep.
View Compound →Transparent Global Sourcing
Manufactured
Sourced through our manufacturing partner in China
Independent Testing
Analytical reports available from Janoshik Analytical
Batch Verification
Batch-specific COAs with online verification via janoshik.com
US Fulfillment
Orders fulfilled from the United States